ScholarIQanswers from OpenAlex & ORCID
Róbert Královics
ResearcherPublications, citations & collaboration network
Róbert Královics is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Róbert Královics have?
ScholarIQindexed works
Róbert Královics has 255 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Róbert Královics have?
ScholarIQcitation count
Róbert Královics has 19,666 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Róbert Královics?
ScholarIQh-index
Róbert Královics has an h-index of 62 in OpenAlex.
What is the i10-index of Róbert Královics?
ScholarIQi10-index
Róbert Královics has an i10-index of 136 in OpenAlex.
What is the ORCID of Róbert Královics?
ScholarIQorcid
The ORCID for Róbert Královics is on the source record.
What is the OpenAlex record for Róbert Královics?
ScholarIQopenalex
The OpenAlex for Róbert Královics is on the source record.
What are the most-cited papers on Róbert Královics?
ScholarIQmost cited works
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease
Alexander Zimprich, Anna Benet‐Pagès, Walter Struhal, Elisabeth Graf, Sebastian Eck, Marc N. Offman, Dietrich Haubenberger, Sabine Spielberger, Eva C. Schulte, Peter Lichtner, Shaila C. Rössle, Norman Klopp, Elisabeth Wolf, Klaus Seppi, Walter Pirker, Stefan Presslauer, Brit Mollenhauer, Regina Katzenschlager, Thomas Foki, Christoph Hotzy, Eva M. Reinthaler, Ashot S. Harutyunyan, Róbert Královics, Annette Peters, Fritz Zimprich, Thomas Brücke, Werner Poewe, Eduard Auff, Claudia Trenkwalder, Burkhard Rost, Gerhard Ransmayr, Juliane Winkelmann, Thomas Meitinger, Tim M. Strom
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
Daniela Pietra, Sai Li, Angela Brisci, Francesco Passamonti, Elisa Rumi, Alexandre Theocharides, Maurizio Ferrari, Heinz Gisslinger, Róbert Královics, Laura Cremonesi, Radek C. Skoda, Mario Cazzola
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study
Berend Snijder, Gregory I. Vladimer, Nikolaus Krall, Katsuhiro Miura, Ann-Sofie Schmolke, Christoph Kornauth, Oscar Lopez de la Fuente, Hye-Soo Choi, Emiel van der Kouwe, Sinan Gültekin, Lukas Kazianka, Johannes W. Bigenzahn, Gregor Hoermann, Nicole Prutsch, Olaf Merkel, Anna Ringler, Monika Sabler, Georg Jeryczynski, Marius E. Mayerhoefer, Ingrid Simonitsch‐Klupp, Katharina Ocko, Franz X. Felberbauer, Leonhard Müllauer, Gerald W. Prager, Belgin Korkmaz, Lukas Kenner, Wolfgang R. Sperr, Róbert Královics, Heinz Gisslinger, Peter Valent, Stefan Kubicek, Ulrich Jäger, Philipp B. Staber, Giulio Superti‐Furga